Growing community of inventors

Bordeaux, France

Stéphanie Monlezun

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Stéphanie MonlezunPier Vincenzo Piazza (2 patents)Stéphanie MonlezunJean-Michel Revest (2 patents)Stéphanie MonlezunRafael Maldonado (5 patents)Stéphanie MonlezunGiovanni Marsicano (2 patents)Stéphanie MonlezunDaniela Cota (2 patents)Stéphanie MonlezunMathilde Metna (2 patents)Stéphanie MonlezunArnau Busquet-Garcia (2 patents)Stéphanie MonlezunMonique Vallee (1 patent)Stéphanie MonlezunSandy Fabre (1 patent)Stéphanie MonlezunMonique Vallée (1 patent)Stéphanie MonlezunSandy Fabre (1 patent)Stéphanie MonlezunAline Marighetto (0 patent)Stéphanie MonlezunAndrés Ozaita (0 patent)Stéphanie MonlezunPier-Vincenzo Piazza (0 patent)Stéphanie MonlezunStéphanie Monlezun (2 patents)Pier Vincenzo PiazzaPier Vincenzo Piazza (6 patents)Jean-Michel RevestJean-Michel Revest (5 patents)Rafael MaldonadoRafael Maldonado (5 patents)Giovanni MarsicanoGiovanni Marsicano (4 patents)Daniela CotaDaniela Cota (4 patents)Mathilde MetnaMathilde Metna (2 patents)Arnau Busquet-GarciaArnau Busquet-Garcia (2 patents)Monique ValleeMonique Vallee (4 patents)Sandy FabreSandy Fabre (2 patents)Monique ValléeMonique Vallée (1 patent)Sandy FabreSandy Fabre (1 patent)Aline MarighettoAline Marighetto (0 patent)Andrés OzaitaAndrés Ozaita (0 patent)Pier-Vincenzo PiazzaPier-Vincenzo Piazza (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitë De Bordeaux (2 from 212 patents)

2. Aelis Farma (2 from 2 patents)

3. Institut National De La Sante Et De La Recherche Medicale (1 from 1,745 patents)

4. Inserm (Institut National De La Sante Et De La Recherche Medicale) (1 from 42 patents)

5. Inserm (0 patent)


2 patents:

1. 12447159 - 3β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related Disorders

2. 11484537 - 3β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…